Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating radionuclide therapies.
Health insurer Centene reported first quarter net income of $1.5 billion despite a 2 million enrollee drop in Obamacare enrollment.
Examples of behavioral changes suggest the power of messaging when disseminated from a bully pulpit. Kennedy’s conspicuous visibility reinforces his reach.
Mike Bloomberg announced an additional $350 million commitment towards road safety against what’s been the leading cause of deaths worldwide for 5 to 29 year olds.
This article addresses the emerging use of adjuncts, such as 3D ultrasound, in breast cancer screening.
A large study found specific benefits of a birth doula on maternal and newborn health outcomes.
TrumpRx has signed deals with 86% of the branded drug market. But are prices actually falling for most Americans? A doctor takes a closer look at who benefits and what’s next.
Why fee-for-service and value-based care are failing, and why only a “moonshot” in healthcare payment models can make care affordable again.
Trump’s orders move the U.S. a few steps closer to more widespread research on and use of two sets of controversial yet promising drugs, psychedelic and cannabis products
Mark Cuban’s Cost Plus Drug Company and Humana’s CenterWell Pharmacy confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”